Skip to main content

Articles

Page 10 of 12

  1. HIV-1 in genital secretions may be opsonized by several molecules including complement components. Opsonized HIV-1 by complement enhances the infection of various mucosal target cells, such as dendritic cells ...

    Authors: Mohammad-Ali Jenabian, Héla Saïdi, Charlotte Charpentier, Hicham Bouhlal, Dominique Schols, Jan Balzarini, Thomas W Bell, Guido Vanham and Laurent Bélec

    Citation: AIDS Research and Therapy 2010 7:16

    Content type: Research

    Published on:

  2. HIV-1 invades the central nervous system (CNS) in the context of acute infection, persists thereafter in the absence of treatment, and leads to chronic intrathecal immunoactivation that can be measured by the ...

    Authors: Lars Hagberg, Paola Cinque, Magnus Gisslen, Bruce J Brew, Serena Spudich, Arabella Bestetti, Richard W Price and Dietmar Fuchs

    Citation: AIDS Research and Therapy 2010 7:15

    Content type: Review

    Published on:

  3. To examine the outcomes of highly-active antiretroviral therapy (HAART) for individuals with free access to healthcare, we evaluated 2327 patients in a cohort study composed of military personnel and beneficia...

    Authors: Vincent C Marconi, Greg A Grandits, Amy C Weintrob, Helen Chun, Michael L Landrum, Anuradha Ganesan, Jason F Okulicz, Nancy Crum-Cianflone, Robert J O'Connell, Alan Lifson, Glenn W Wortmann and Brian K Agan

    Citation: AIDS Research and Therapy 2010 7:14

    Content type: Research

    Published on:

  4. Interventions to promote prevention and earlier diagnosis of severe symptomatic hyperlactataemia (SHL) were implemented in the Western Cape provincial antiretroviral programme (South Africa) from 2004. Interve...

    Authors: Charlotte Schutz, Andrew Boulle, Dave Stead, Kevin Rebe, Meg Osler and Graeme Meintjes

    Citation: AIDS Research and Therapy 2010 7:13

    Content type: Research

    Published on:

  5. After the introduction of highly active antiretroviral therapies (HAART), an increased incidence of insulin resistance, diabetes mellitus (DM), and cardiovascular diseases has been described. The impact of suc...

    Authors: Diego Serraino, Silvia Bruzzone, Antonella Zucchetto, Barbara Suligoi, Angela De Paoli, Simona Pennazza, Laura Camoni, Luigino Dal Maso, Paoli De Paoli and Giovanni Rezza

    Citation: AIDS Research and Therapy 2010 7:11

    Content type: Short report

    Published on:

  6. South Africa, with its scientific capacity, good infrastructure and high HIV incidence rates, is ideally positioned to conduct large-scale HIV prevention trials. The HIV Prevention Research Unit of the South A...

    Authors: Gita Ramjee, Nicola Coumi, Nozizwe Dladla-Qwabe, Shay Ganesh, Sharika Gappoo, Roshini Govinden, Vijayanand Guddera, Rashika Maharaj, Jothi Moodley, Neetha Morar, Sarita Naidoo and Thesla Palanee

    Citation: AIDS Research and Therapy 2010 7:10

    Content type: Research

    Published on:

  7. Abacavir (ABC) treatment has been associated with an increased incidence of myocardial infarction. The pathophysiological mechanism is unknown. In this study markers of inflammation and coagulation in HIV-infe...

    Authors: Eefje Jong, Joost CM Meijers, Eric CM van Gorp, C Arnold Spek and Jan W Mulder

    Citation: AIDS Research and Therapy 2010 7:9

    Content type: Short report

    Published on:

  8. Cytochrome P450 2B6 (CYP2B6) metabolizes efavirenz and nevirapine, the major core antiretroviral drugs for HIV in Thailand. Rifampicin, a critical component of tuberculosis (TB) therapy is a potent inducer of CYP...

    Authors: Sumonmal Uttayamakul, Sirirat Likanonsakul, Weerawat Manosuthi, Nuanjun Wichukchinda, Thareerat Kalambaheti, Emi E Nakayama, Tatsuo Shioda and Srisin Khusmith

    Citation: AIDS Research and Therapy 2010 7:8

    Content type: Research

    Published on:

  9. Current therapy for human immunodeficiency virus (HIV-1) infection relies primarily on the administration of anti-retroviral nucleoside analogues, either alone or in combination with HIV-protease inhibitors. A...

    Authors: Irene Guendel, Emmanuel T Agbottah, Kylene Kehn-Hall and Fatah Kashanchi

    Citation: AIDS Research and Therapy 2010 7:7

    Content type: Research

    Published on:

  10. Smoking prevalence in human immunodeficiency virus (HIV) positive subjects is about three times of that in the general population. However, whether the extremely high smoking prevalence in HIV-positive subject...

    Authors: Qu Cui, Sue Carruthers, Andrew McIvor, Fiona Smaill, Lehana Thabane and Marek Smieja

    Citation: AIDS Research and Therapy 2010 7:6

    Content type: Research

    Published on:

  11. Ritonavir-boosted saquinavir (SQVr) is nowadays regarded as an alternative antiretroviral drug probably due to several drawbacks, such as its high pill burden, twice daily dosing and the requirement of 200 mg ...

    Authors: Luis F López-Cortés, Pompeyo Viciana, Rosa Ruiz-Valderas, Juan Pasquau, Josefa Ruiz, Fernando Lozano, Dolores Merino, Antonio Vergara, Alberto Terrón, Luis González, Antonio Rivero and Agustin Muñoz-Sanz

    Citation: AIDS Research and Therapy 2010 7:5

    Content type: Research

    Published on:

  12. HIV-1 infected patients for whom standard gp160 phenotypic tropism testing failed are currently excluded from co-receptor antagonist treatment. To provide patients with maximal treatment options, massively par...

    Authors: Ina Vandenbroucke, Herwig Van Marck, Wendy Mostmans, Veerle Van Eygen, Evelien Rondelez, Kim Thys, Kurt Van Baelen, Katrien Fransen, Dolores Vaira, Kabamba Kabeya, Stephane De Wit, Eric Florence, Michel Moutschen, Linos Vandekerckhove, Chris Verhofstede and Lieven J Stuyver

    Citation: AIDS Research and Therapy 2010 7:4

    Content type: Research

    Published on:

  13. International HIV guidelines have recently shifted from a medium-late to an early-start treatment strategy. As a consequence, more people will be eligible to Highly Active Antiretroviral Therapy (HAART). We es...

    Authors: Kjell Arne Johansson, Bjarne Robberstad and Ole Frithjof Norheim

    Citation: AIDS Research and Therapy 2010 7:3

    Content type: Research

    Published on:

  14. Adequate antiretroviral drug potency is essential for obtaining therapeutic benefit, however, the behavioral aspects of proper adherence and readiness to medication, often determine therapeutic outcome. Theref...

    Authors: Belay Tessema, Fantahun Biadglegne, Andargachew Mulu, Assefa Getachew, Frank Emmrich and Ulrich Sack

    Citation: AIDS Research and Therapy 2010 7:2

    Content type: Research

    Published on:

  15. A recent study reported a lower than expected specificity and positive predictive value of the rapid oral HIV test in the setting of routine emergency department (ED) screening. These results appeared inconsis...

    Authors: Jeremy Brown, Manya Magnus, Maggie Czarnogosrki and Vanessa Lee

    Citation: AIDS Research and Therapy 2010 7:1

    Content type: Research

    Published on:

  16. Different strategies of ritonavir-boosted lopinavir monotherapy have been explored; however, data regarding salvage therapy among HIV-infected patients who failed nucleoside reverse transcriptase inhibitor (NR...

    Authors: Weerawat Manosuthi, Sasisopin Kiertiburanakul, Wannarat Amornnimit, Wisit Prasithsirikul, Supeda Thongyen, Samruay Nilkamhang, Kiat Ruxrungtham and Somnuek Sungkanuparph

    Citation: AIDS Research and Therapy 2009 6:30

    Content type: Research

    Published on:

  17. Lopinavir/ritonavir (LPV/r) tablet compared to the soft gel capsule (SGC) formulation has no oleic acid or sorbitol, has no refrigeration or food-restriction requirements, and has less pharmacokinetic variabil...

    Authors: Ighovwerha Ofotokun, Susan K Chuck, Brian Schmotzer and Kelly L O'Neil

    Citation: AIDS Research and Therapy 2009 6:29

    Content type: Research

    Published on:

  18. HIV-1 epidemic in India is largely driven by subtype C but other subtypes or recombinants have also been reported from several states of India. This is mainly due to the co-circulation of other genetic subtype...

    Authors: Ujjwal Neogi, Vikas Sood, Arpita Chowdhury, Shukla Das, Vishnampettai G Ramachandran, Vijesh K Sreedhar, Ajay Wanchu, Nilanjana Ghosh and Akhil C Banerjea

    Citation: AIDS Research and Therapy 2009 6:28

    Content type: Short report

    Published on:

  19. With the advent of entry inhibitors, monitoring of viral tropism in the clinical setting is important. Conventional methods are cell-based and lengthy, therefore V3 sequence based prediction algorithms are bec...

    Authors: Viswanath Ragupathy, Jiangqin Zhao, Xue Wang, Owen Wood, Sherwin Lee, Sherri Burda, Phillipe Nyambi and Indira Hewlett

    Citation: AIDS Research and Therapy 2009 6:27

    Content type: Short report

    Published on:

  20. Fenofibrate changed the expression of chemokine genes in circulating leukocytes of HIV-infected patients with hypertriglyceridemia. The data suggest that fenofibrate when effective in the treatment of lipoprot...

    Authors: Carlos Alonso-Villaverde, Gerard Aragonès, Raúl Beltrán-Debón, Laura Fernández-Sender, Anna Rull, Jordi Camps, Josep M Alegret and Jorge Joven

    Citation: AIDS Research and Therapy 2009 6:26

    Content type: Short report

    Published on:

  21. Snake and insect venoms have been demonstrated to have beneficial effects in the treatment of certain diseases including drug resistant human immunodeficiency virus (HIV) infection. We evaluated and hypothesiz...

    Authors: Ramachandran Meenakshisundaram, Shah Sweni and Ponniah Thirumalaikolundusubramanian

    Citation: AIDS Research and Therapy 2009 6:25

    Content type: Review

    Published on:

  22. WR1065 is the free-thiol metabolite of the cytoprotective aminothiol amifostine, which is used clinically at very high doses to protect patients against toxicity induced by radiation and chemotherapy. In an ea...

    Authors: Miriam C Poirier, Ofelia A Olivero, Andrew W Hardy, Genoveffa Franchini, Jennifer P Borojerdi, Vernon E Walker, Dale M Walker and Gene M Shearer

    Citation: AIDS Research and Therapy 2009 6:24

    Content type: Research

    Published on:

  23. Non-nucleoside reverse transcriptase inhibitors (NNRTIs) are an important category of drugs for both chemotherapy and prevention of human immunodeficiency virus type 1 (HIV-1) infection. However, current non-h...

    Authors: Yonghou Jiang, Baoping Tian, Mohammed Saifuddin, Michael B Agy, Peter Emau, J Scott Cairns and Che-Chung Tsai

    Citation: AIDS Research and Therapy 2009 6:23

    Content type: Research

    Published on:

  24. A high incidence of rash has been reported in HIV-1 patients who received the anti-retroviral drug nevirapine. In addition, several studies have suggested that polymorphisms of human leukocyte antigen (HLA) genes...

    Authors: Sirirat Likanonsakul, Tippawan Rattanatham, Siriluk Feangvad, Sumonmal Uttayamakul, Wisit Prasithsirikul, Preecha Tunthanathip, Emi E Nakayama and Tatsuo Shioda

    Citation: AIDS Research and Therapy 2009 6:22

    Content type: Research

    Published on:

  25. With African health-care systems facing exploding demand for HIV care, reliable methods for assessing adherence and its influencing factors are needed to guide effective public-health measures. This study eval...

    Authors: Mathieu Rougemont, Beat E Stoll, Nadia Elia and Peter Ngang

    Citation: AIDS Research and Therapy 2009 6:21

    Content type: Research

    Published on:

  26. HIV-1 infects gut associated lymphoid tissues (GALT) very early after transmission by multiple routes. The infected GALT consequently serves as the major reservoir for HIV-1 infection and could constantly shed...

    Authors: Ayan K Chakrabarti, Lori Caruso, Ming Ding, Chengli Shen, William Buchanan, Phalguni Gupta, Charles R Rinaldo and Yue Chen

    Citation: AIDS Research and Therapy 2009 6:20

    Content type: Research

    Published on:

  27. Protease inhibitors such as ritonavir can cause nausea and vomiting which is the most common reason for discontinuation. Rats react to nauseous and emetic stimuli by increasing their oral intake of non-nutriti...

    Authors: Chun-Su Yuan, Chong-Zhi Wang, Sangeeta R Mehendale, Han H Aung, Adela Foo and Robert J Israel

    Citation: AIDS Research and Therapy 2009 6:19

    Content type: Research

    Published on:

  28. Roche's protease inhibitor nelfinavir mesylate (Viracept®) produced between March 2007-June 2007 was found to contain elevated levels of ethyl methanesulfonate (EMS), a known mutagen (alkylator) – leading to a gl...

    Authors: Anton Pozniak, Lutz Müller, Miklos Salgo, Judith K Jones, Peter Larson and David Tweats

    Citation: AIDS Research and Therapy 2009 6:18

    Content type: Short report

    Published on:

  29. Many HIV-infected patients only access health care once they have developed advanced symptomatic disease resulting from AIDS Defining Conditions (ADCs). We carried out a study to establish the effect of ADCs o...

    Authors: Brian K Kigozi, Samwel Sumba, Peter Mudyope, Betty Namuddu, Joan Kalyango, Charles Karamagi, Mathew Odere, Elly Katabira, Peter Mugyenyi and Francis Ssali

    Citation: AIDS Research and Therapy 2009 6:17

    Content type: Research

    Published on:

  30. To immunophenotype CD4+ and CD8+ T cell sub-populations in HIV-associated immune reconstitution inflammatory syndrome (IRIS).

    Authors: David M Murdoch, Melinda S Suchard, Willem DF Venter, Patrick Mhlangu, Janet S Ottinger, Charles Feldman, Annelies Van Rie, Deborah K Glencross, Wendy S Stevens and Kent J Weinhold

    Citation: AIDS Research and Therapy 2009 6:16

    Content type: Research

    Published on:

  31. The latency of HIV-1 in resting CD4+ T-lymphocytes constitutes a major obstacle for the eradication of virus in patients on antiretroviral therapy (ART). As yet, no approach to reduce this viral reservoir has pro...

    Authors: Annica Lindkvist, Arvid Edén, Melissa M Norström, Veronica D Gonzalez, Staffan Nilsson, Bo Svennerholm, Annika C Karlsson, Johan K Sandberg, Anders Sönnerborg and Magnus Gisslén

    Citation: AIDS Research and Therapy 2009 6:15

    Content type: Research

    Published on:

  32. HIV-1 integrase (IN) is an attractive target for the development of drugs to treat AIDS, and inhibitors of this viral enzyme are already in the clinic. Nevertheless, there is a continuing need to devise new ap...

    Authors: Mark D Andrake, Joseph Ramcharan, George Merkel, Xue Zhi Zhao, Terrence R Burke Jr and Anna Marie Skalka

    Citation: AIDS Research and Therapy 2009 6:14

    Content type: Methodology

    Published on:

  33. Antiretrovirals used to treat HIV-infected patients have the potential to adversely affect serum lipid profiles and increase the risk of cardiovascular disease which is an emerging concern among HIV-infected p...

    Authors: Anuradha Ganesan, Lorie Benning, Elizabeth T Golub, Mark Riddle, Nancy Crum-Cianflone, Sybil Tasker, Lisa Jacobson and Stephen J Gange

    Citation: AIDS Research and Therapy 2009 6:13

    Content type: Short report

    Published on:

  34. Access to antiretroviral therapy (ART) is increasing in resource-limited settings (RLS) and can successfully reduce HIV-related morbidity and mortality. However, virologic failure and development of viral drug...

    Authors: Kim Steegen, Stanley Luchters, Kenny Dauwe, Jacqueline Reynaerts, Kishor Mandaliya, Walter Jaoko, Jean Plum, Marleen Temmerman and Chris Verhofstede

    Citation: AIDS Research and Therapy 2009 6:12

    Content type: Short report

    Published on:

  35. Non-invasive surrogate measures which are valid and responsive to change are needed to study cardiovascular risks in HIV. We compared the construct validity of two noninvasive arterial measures: carotid intima...

    Authors: Adefowope Odueyungbo, Marek Smieja, Lehana Thabane, Fiona Smaill, Kevin Gough, John Gill, Todd Anderson, Dawn Elston, Sandy Smith, Joseph Beyene and Eva Lonn

    Citation: AIDS Research and Therapy 2009 6:11

    Content type: Research

    Published on:

  36. Two HIV-1 infected patients developed signs and symptoms consistent with adrenal suppression after being exposed to intra-articular triamcinolone acetate while also receiving ritonavir as part of their highly ...

    Authors: Kathryn Dort, Shetal Padia, Brian Wispelwey and Christopher C Moore

    Citation: AIDS Research and Therapy 2009 6:10

    Content type: Case report

    Published on:

  37. Successful treatment of HIV-positive patients is fundamental to controlling the progression to AIDS. Causes of treatment failure are either related to drug resistance and/or insufficient drug levels in the blo...

    Authors: IRichard Thompson, Penelope Bidgood, Andrea Petróczi, James CW Denholm-Price and Mark D Fielder

    Citation: AIDS Research and Therapy 2009 6:9

    Content type: Hypothesis

    Published on:

  38. Fat abnormalities are common among HIV-infected persons, but few studies have compared regional body fat distribution, including visceral fat, in HIV-infected and HIV-uninfected persons and their subsequent tr...

    Authors: Todd T Brown, Xiaoqiang Xu, Majnu John, Jaya Singh, Lawrence A Kingsley, Frank J Palella, Mallory D Witt, Joseph B Margolick and Adrian S Dobs

    Citation: AIDS Research and Therapy 2009 6:8

    Content type: Research

    Published on:

  39. Human Immunodeficiency Virus (HIV) has an estimated prevalence of 0.9% in India (5.2 million). Anti-retroviral drugs (ARV) are the treatments of choice and non-adherence is an important factor in treatment failur...

    Authors: Mary B Cauldbeck, Catherine O'Connor, Mortimer B O'Connor, Jean A Saunders, Bhimasena Rao, V G Mallesh, Nagendrappa Kotehalappa Praveen Kumar, Gurushanthappa Mamtha, Claire McGoldrick, Robert BS Laing and Kadappa Shivappa Satish

    Citation: AIDS Research and Therapy 2009 6:7

    Content type: Research

    Published on:

  40. Prognosis for patients with the human immunodeficiency virus (HIV) has improved with the introduction of highly active antiretroviral therapy (HAART). Evidence over recent years suggests that the incidence of ...

    Authors: Julián Olalla, Daniel Salas, Javier de la Torre, Alfonso del Arco, José Luis Prada, Francisco Martos, Emilio Perea-Milla and Javier García-Alegría

    Citation: AIDS Research and Therapy 2009 6:6

    Content type: Review

    Published on:

  41. Most in vitro assays of drug potency may not adequately predict the performance in vivo. Methods to assess the persistence of antiviral activity of deoxynucleoside analogs, which require intracellular activati...

    Authors: Elijah Paintsil, Susan P Grill, Ginger E Dutschman and Yung-Chi Cheng

    Citation: AIDS Research and Therapy 2009 6:5

    Content type: Research

    Published on:

  42. About 20–30% of persons with HIV infection, especially those living in countries with limited resources, experience an immune reconstitution inflammatory syndrome (IRIS) after starting antiretroviral treatment...

    Authors: Anali Conesa-Botella, Chantal Mathieu, Robert Colebunders, Rodrigo Moreno-Reyes, Evelyne van Etten, Lut Lynen and Luc Kestens

    Citation: AIDS Research and Therapy 2009 6:4

    Content type: Hypothesis

    Published on:

  43. Traditional first line regimens containing a non-nucleoside reverse transcriptase inhibitor or protease inhibitor may not be suitable for a subset of antiretroviral-naïve patients such as those with certain co...

    Authors: Princy N Kumar, Patricia Salvato, Anthony LaMarca, Edwin DeJesus, Parul Patel, Daniel McClernon, Allison Florance and Mark S Shaefer

    Citation: AIDS Research and Therapy 2009 6:3

    Content type: Research

    Published on:

  44. The selection of agents for any treatment regimen is in part influenced by physician and patient attitudes. This study investigated attitudinal motivators and barriers to the use of self-injectable antiretrovi...

    Authors: Robert Horne, Colin Kovacs, Christine Katlama, Bonaventura Clotet, Carmina R Fumaz, Michael Youle, Ranjababu Kulasegaram, Martin Fisher, Calvin Cohen, Jihad Slim, Peter Shalit, Vanessa Cooper and Christos Tsoukas

    Citation: AIDS Research and Therapy 2009 6:2

    Content type: Research

    Published on:

  45. HIV-infected individuals are at increased risk for acute and chronic airway disease even though there is no evidence that the virus can infect the lung epithelium. Although HIV-related proteins including gp120...

    Authors: Coy Lassiter, Xian Fan, Pratibha C Joshi, Barbara A Jacob, Roy L Sutliff, Dean P Jones, Michael Koval and David M Guidot

    Citation: AIDS Research and Therapy 2009 6:1

    Content type: Research

    Published on:

  46. CD4 count is a standard measure of immunodeficiency in adults infected with HIV to initiate and monitor highly active antiretroviral therapy; however, it may not be feasible in resource poor countries. There i...

    Authors: Deresse Daka and Eskindir Loha

    Citation: AIDS Research and Therapy 2008 5:26

    Content type: Research

    Published on:

  47. Allopathic practitioners in India are outnumbered by practitioners of traditional Indian medicine and homeopathy (TIMH), which is used by up to two-thirds of its population to help meet primary health care nee...

    Authors: M Fritts, CC Crawford, D Quibell, A Gupta, WB Jonas, I Coulter and SA Andrade

    Citation: AIDS Research and Therapy 2008 5:25

    Content type: Research

    Published on:

  48. To evaluate the feasibility of a large immediate versus deferred antiretroviral therapy (ART) study in children.

    Authors: Jintanat Ananworanich, Pope Kosalaraksa, Umaporn Siangphoe, Chulapan Engchanil, Chitsanu Pancharoen, Pagakrong Lumbiganon, Jintana Intasan, Wichitra Apateerapong, Theshinee Chuenyam, Sasiwimol Ubolyam, Torsak Bunupuradah, Joep Lange, David A Cooper and Praphan Phanuphak

    Citation: AIDS Research and Therapy 2008 5:24

    Content type: Research

    Published on:

  49. A proportion of individuals who start antiretroviral therapy (ART) fail to achieve adequate CD4 cell reconstitution despite sustained viral suppression. We determined the frequency and clinical significance of...

    Authors: Damalie Nakanjako, Agnes Kiragga, Fowzia Ibrahim, Barbara Castelnuovo, Moses R Kamya and Philippa J Easterbrook

    Citation: AIDS Research and Therapy 2008 5:23

    Content type: Research

    Published on: